Which groundbreaking medical product, launched in 2003, became the first FDA-approved monoclonal antibody treatment that specifically targets the TNF-alpha protein to treat autoimmune diseases?

The pharmaceutical and medical device industries have seen numerous groundbreaking product launches that transformed healthcare. Some launches created entirely new therapeutic categories, while others dramatically improved existing treatments. This trivia tests your knowledge about one of the most significant medical product launches of the 21st century that changed treatment paradigms and patient outcomes.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Humira (adalimumab)
Keytruda (pembrolizumab)
Sovaldi (sofosbuvir)
Ozempic (semaglutide)